Gálvez‐Cancino et al. (2018) showed that intradermal administration of vaccines, which are known to induce strong CD8+ T‐cell responses, efficiently induced TRM cell responses against tumor antigens and self‐antigens (Gálvez‐Cancino et al., 2018) (Figure 4). Here, CD8A is linked to neoplasm.